Form 8-K - Current report:
SEC Accession No. 0001161697-24-000423
Filing Date
2024-10-28
Accepted
2024-10-28 15:03:09
Documents
14
Period of Report
2024-08-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 08-08-2024 form_8-k.htm   iXBRL 8-K 19831
2 GRAPHIC globestar_logo.jpg GRAPHIC 10744
  Complete submission text file 0001161697-24-000423.txt   221162

Data Files

Seq Description Document Type Size
3 INLINE XBRL SCHEMA FILE gstc-20240808.xsd EX-101.SCH 3018
4 INLINE XBRL LABEL FILE gstc-20240808_lab.xml EX-101.LAB 34240
5 INLINE XBRL PRESENTATION FILE gstc-20240808_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT form_8-k_htm.xml XML 3664
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 509-531-1671
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 241400351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)